Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Appl Microbiol ; 121(1): 101-14, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26999597

RESUMO

AIMS: The biofilm produced by Staphylococcus aureus isolates involved in clinical or subclinical bovine mastitis and the activity of nisin and lysostaphin against the preformed biofilm produced by these strains were investigated. METHODS AND RESULTS: Eighteen strains were tested and all produced biofilm. Eight strains with distinct biofilm composition were selected for the antimicrobial activity assays. The minimal inhibitory concentration of each bacteriocin was determined against the planktonic cells and ranged from 15·6 to 500 µg ml(-1) for nisin, and from 3·9 to 50 µg ml(-1) , for lysostaphin. Lysostaphin treatment (0·4 µg ml(-1) ) for 4 h caused a strong Staph. aureus 4181 biofilm detachment and death of the majority of the sessile cells, while nisin treatment (100 µg ml(-1) ) for the same time caused only a great reduction in cell viability. Additionally, combination of both bacteriocins for 4 h resulted in significant death of the sessile cells but no biofilm detachment. CONCLUSIONS: The treatment with lysostaphin alone or in combination with nisin was effective in killing most biofilm sessile cells. SIGNIFICANCE AND IMPACT OF THE STUDY: The action of lysostaphin, either alone or in combination with nisin, against established staphylococcal biofilm may represent an alternative to bovine mastitis control. However, the duration of the treatment should be considered for its application so that the best effectiveness can be achieved.


Assuntos
Biofilmes/efeitos dos fármacos , Lisostafina/farmacologia , Mastite Bovina/tratamento farmacológico , Nisina/farmacologia , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/efeitos dos fármacos , Animais , Antibacterianos/farmacologia , Bovinos , Sobrevivência Celular/efeitos dos fármacos , Feminino , Lisostafina/uso terapêutico , Testes de Sensibilidade Microbiana/métodos , Nisina/uso terapêutico , Plâncton/efeitos dos fármacos , Staphylococcus aureus/fisiologia
2.
Microbes Infect ; 14(14): 1340-51, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23010292

RESUMO

Several intracellular pathogens are internalized by host cells via multiple endocytic pathways. It is no different with Trypanosoma cruzi. Evidences indicate that T. cruzi entry may occur by endocytosis/phagocytosis or by an active manner. Although macropinocytosis is largely considered an endocytic process where cells internalize only large amounts of solutes, several pathogens use this pathway to enter into host cells. To investigate whether T. cruzi entry into peritoneal macrophages and LLC-MK2 epithelial cells can be also mediated through a macropinocytosis-like process, we used several experimental strategies presently available to characterize macropinocytosis such as the use of different inhibitors. These macropinocytosis' inhibitors blocked internalization of T. cruzi by host cells. To further support this, immunofluorescence microscopy and scanning electron microscopy techniques were used. Field emission scanning electron microscopy revealed that after treatment, parasites remained attached to the external side of host cell plasma membrane. Proteins such as Rabankyrin 5, tyrosine kinases, Pak1 and actin microfilaments, which participate in macropinosome formation, were localized at T. cruzi entry sites. We also observed co-localization between the parasite and an endocytic fluid phase marker. All together, these results indicate that T. cruzi is able to use multiple mechanisms of penetration into host cell, including macropinocytosis.


Assuntos
Doença de Chagas/parasitologia , Pinocitose/fisiologia , Trypanosoma cruzi/fisiologia , Acetofenonas/farmacologia , Citoesqueleto de Actina/metabolismo , Amilorida/farmacologia , Análise de Variância , Animais , Benzopiranos/farmacologia , Linhagem Celular , Células Cultivadas , Dissulfetos/farmacologia , Interações Hospedeiro-Parasita , Macaca mulatta , Macrófagos Peritoneais/metabolismo , Macrófagos Peritoneais/parasitologia , Proteínas de Membrana/metabolismo , Camundongos , Microscopia de Fluorescência , Naftóis/farmacologia , Pinocitose/efeitos dos fármacos , Trypanosoma cruzi/efeitos dos fármacos , Trypanosoma cruzi/patogenicidade , Vacúolos/efeitos dos fármacos , Vacúolos/metabolismo , Quinases Ativadas por p21/metabolismo
3.
Biochem Biophys Res Commun ; 363(3): 828-34, 2007 Nov 23.
Artigo em Inglês | MEDLINE | ID: mdl-17904520

RESUMO

Membrane rafts are small and dynamic regions enriched in sphingolipids, cholesterol, ganglioside GM1 and protein markers like flotillins, forming the flatter domains or caveolins, which are characterized as stable flask-shape invaginations. We explored whether membrane rafts participate in the entry of Trypanosoma cruzi's trypomastigotes into murine macrophages through transient depletion of macrophage membrane cholesterol with methyl-beta-cyclodextrin and treatment with filipin. These treatments led to a decrease in the trypomastigote invasion process. Macrophage pre incubated with increasing concentrations of cholera toxin B, that binds GM1, inhibited the adhesion and invasion of trypomastigote and amastigote forms. Immunofluorescence analysis demonstrated a colocalization of GM1, flotillin 1 and caveolin 1 in the T. cruzi parasitophorous vacuole. Taken together these data suggest that membrane rafts, including caveolae, are involved in the process of T. cruzi invasion of macrophages.


Assuntos
Macrófagos Peritoneais/parasitologia , Microdomínios da Membrana/parasitologia , Trypanosoma cruzi/crescimento & desenvolvimento , Animais , Cavéolas/efeitos dos fármacos , Cavéolas/metabolismo , Cavéolas/parasitologia , Caveolina 1/análise , Toxina da Cólera/farmacologia , Colesterol/metabolismo , Endocitose , Filipina/farmacologia , Gangliosídeo G(M1)/análise , Macrófagos Peritoneais/citologia , Macrófagos Peritoneais/efeitos dos fármacos , Microdomínios da Membrana/efeitos dos fármacos , Microdomínios da Membrana/metabolismo , Proteínas de Membrana/análise , Camundongos , Microscopia Confocal , Trypanosoma cruzi/efeitos dos fármacos , Trypanosoma cruzi/metabolismo , beta-Ciclodextrinas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...